Concepedia

J.L. Lee

JL

Statistics

Publications

1

Citations

15

H-Index

1

Active since

2023

Affiliations

Seoul National University Hospital(Current)

J.L. Lee is an author at Seoul National University Hospital specializing in checkpoint inhibitor therapy, mek inhibitors, and antitumor t cell responses.

Publications per year

2023–2023

1

Publications

1

Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study

Eric J. Sherman, J.L. Lee, Philip R. Debruyne et al. · ESMO Open · 2023 · 15 citations · Full text

, , +17

1–1 of 1